Synapsoft logo
AI Insights from Disclosures
Searching...
HLB Pep Co., Ltd. 196300
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
AniGen Co., Ltd. (hereinafter the company) develops peptide biomaterials (for industrial and pharmaceutical use) and globally innovative new drugs, discovering new drug candidates for breast cancer, gastric cancer, colorectal cancer, and viruses, and building core pipelines based on its APsoluT (AGM-330) platform technology, while conducting research and development through networking with top experts in the field in Korea and abroad.
Representative Director 심경재 (단독 대표)
Founded May 2, 2000
Corporation Type KOSDAQ
Industry Classification Manufacture of medicinal chemicals
Corporate number 20011-0115802
Business number 409-81-53794
Phone Number 062-714-1166
Fax Number 062-714-1188
Company Address 333 Cheomdangwagi-ro, Buk-gu, Jeonnam-Gwangju
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant